Immunology has increasingly taken centerstage in modern biomedicine, powerfully capturing the popular imagination. From revolutionising vaccine development during the COVID-19 pandemic to yielding profound insights into autoimmune disorders and…
Category: 6. Health
-
expert reaction to conference abstract on the DYNAMIC-III study on ctDNA-guided adjuvant chemotherapy de-escalation in stage III colon cancer
A conference abstract presented at the European Society for Medical Oncology (ESMO) 2025 meeting looks at…
Continue Reading
-
Last Ebola patient discharged in DR Congo, WHO says | Ebola News
Barring new cases, the patient’s recovery kicks off a 42-day countdown to declaring the country’s 16th outbreak over.
Published On 19 Oct 2025
The last Ebola patient in the Democratic…
Continue Reading
-
Sabine Brookman-May: Exploring Clinical Benefit of Enza+ADT in Prostate Cancer at ESMO25
Sabine Brookman-May, Senior Vice President and Therapeutic Area Head of Urologic Oncology at Aura Biosciences, shared a post on X by Neeraj Agarwal, Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute…
Continue Reading
-
Enzalutamide Combo Shows No MFS Improvement in Advanced Prostate Cancer
The phase 3 ENZARAD (ANZUP 1303) trial (NCT02446444) showed no improvement in metastasis-free survival (MFS) with the addition of enzalutamide (Xtandi) to androgen deprivation therapy (ADT) and high-dose radiation among those with high-risk…
Continue Reading
-
Hostages’ individual rehabilitation timelines | The Jerusalem Post
Hostages’ individual rehabilitation timelines | The Jerusalem Post Continue Reading
-
Ebola outbreak reaches 42-day countdown
The World Health Organization (WHO) reported today that the last Ebola patient in the Democratic Republic of the Congo was discharged today. No new cases have been reported since 25 September.
This starts the 42-day countdown to declaring the…
Continue Reading
